Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$ntlas Graphic](https://lunarcrush.com/gi/w:26/t:$ntlas.png) $ntlas

Intellia Therapeutics faces scrutiny over genome editing safety, with critics pointing to alternative therapies. Discussions also highlight the comparison between Intellia and Sarepta Therapeutics' approaches.

### About $ntlas
NTLA is likely referring to Intellia Therapeutics, a genome editing company.  

### Insights [#](/topic/$ntlas/insights)
- $ntlas Creators hit a high of X for the day
- $ntlas Creators hit an all time of X for the day
- $ntlas Mentions hit a high of X for the day
- $ntlas Mentions hit an all time of X for the day

### Engagements: XX [#](/topic/$ntlas/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ntlas/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$ntlas/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-05-29  
**1-Year Low**: X on 2025-06-18  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$ntlas/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ntlas/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$ntlas/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-07-25  
**1-Year Low**: X on 2025-05-08  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$ntlas/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ntlas/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$ntlas/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ntlas in the last XX hours which is down XX% from X in the previous XX hours
**Daily Average**: X  
**1 Month**: X -XX%  
**1-Year High**: X on 2025-07-25  
**1-Year Low**: X on 2025-05-08  

**Top assets mentioned**
In the posts about $ntlas in the last XX hours

[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)

**Top topics mentioned**
In the posts about $ntlas in the last XX hours

[$alny](/topic/$alny), [genome](/topic/genome), [$srpt](/topic/$srpt), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [avg](/topic/avg), [coins real estate](/topic/coins-real-estate), [$95m](/topic/$95m), [$76356m8](/topic/$76356m8), [voodoo](/topic/voodoo), [$srpts](/topic/$srpts)

### Top Social Posts [#](/topic/$ntlas/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@GeneInvesting @john_hersc79276 Wait once @adamfeuerstein is done with the $srpt beat he'll return to the $NTLA's genome editing is dangerous one especially if there are alternative therapies. Wait for it ;). $alny $bbio"  
[@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1948435492971618685) 2025-07-24 17:29:56 UTC 19.7K followers, 1203 engagements


"@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin"  
[@FidelisAurelius](/creator/x/FidelisAurelius) on [X](/post/tweet/1947672097741783071) 2025-07-22 14:56:28 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$ntlas Graphic $ntlas

Intellia Therapeutics faces scrutiny over genome editing safety, with critics pointing to alternative therapies. Discussions also highlight the comparison between Intellia and Sarepta Therapeutics' approaches.

About $ntlas

NTLA is likely referring to Intellia Therapeutics, a genome editing company.

Insights #

  • $ntlas Creators hit a high of X for the day
  • $ntlas Creators hit an all time of X for the day
  • $ntlas Mentions hit a high of X for the day
  • $ntlas Mentions hit an all time of X for the day

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-05-29
1-Year Low: X on 2025-06-18

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-07-25
1-Year Low: X on 2025-05-08

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ntlas in the last XX hours which is down XX% from X in the previous XX hours Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-07-25
1-Year Low: X on 2025-05-08

Top assets mentioned In the posts about $ntlas in the last XX hours

Alnylam Pharmaceuticals, Inc. (ALNY) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT)

Top topics mentioned In the posts about $ntlas in the last XX hours

$alny, genome, $srpt, sarepta therapeutics inc, avg, coins real estate, $95m, $76356m8, voodoo, $srpts

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"@GeneInvesting @john_hersc79276 Wait once @adamfeuerstein is done with the $srpt beat he'll return to the $NTLA's genome editing is dangerous one especially if there are alternative therapies. Wait for it ;). $alny $bbio"
@RNAiAnalyst on X 2025-07-24 17:29:56 UTC 19.7K followers, 1203 engagements

"@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin"
@FidelisAurelius on X 2025-07-22 14:56:28 UTC XXX followers, XXX engagements

$ntlas
/topic/$ntlas